Habib A
Department of Ear,Nose and Throat,Nottingham University Hospitals NHS Trust,Nottingham City Hospital,UK.
J Laryngol Otol. 2018 May;132(5):385-400. doi: 10.1017/S0022215118000555.
Advanced hypopharyngeal carcinoma has a dismal prognosis. The optimal treatment for these patients remains under debate. This systematic review aimed to compare survival following surgical and non-surgical treatments.
A systematic review was conducted of randomised studies, with a descriptive analysis of retrospective observational studies.
Two randomised trials and 11 observational studies were included in the review. A meta-analysis of randomised trials reported a hazard ratio of 0.89 for overall survival in favour of surgical treatment (p = 0.44). Neither treatment was favoured in terms of overall survival. Observational studies did not report a survival advantage with either treatment. The five-year larynx preservation rates for non-surgically treated patients were between 38 and 58 percent.
Chemoradiotherapy offers similar survivorship compared to surgery in advanced disease, while also making larynx preservation feasible. It can be used as a treatment in all patients as an alternative to surgery.
晚期下咽癌预后不佳。这些患者的最佳治疗方案仍存在争议。本系统评价旨在比较手术治疗和非手术治疗后的生存率。
对随机研究进行系统评价,并对回顾性观察性研究进行描述性分析。
该评价纳入了两项随机试验和11项观察性研究。随机试验的荟萃分析报告显示,手术治疗的总生存风险比为0.89(p = 0.44)。在总生存方面,两种治疗方法均无优势。观察性研究未报告任何一种治疗方法具有生存优势。非手术治疗患者的五年喉保留率在38%至58%之间。
在晚期疾病中,放化疗与手术相比具有相似的生存率,同时也使喉保留成为可能。它可作为所有患者手术替代方案的一种治疗方法。